Risk Factors for Potential Drug -Drug Interactions: Study in Surgical Intensive Care Unit -Zagazig University Hospitals.
NCT ID: NCT04078620
Last Updated: 2019-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
120 participants
OBSERVATIONAL
2018-06-15
2019-04-20
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Drug-drug Interactions With Anti-tuberculous Drugs
NCT06381375
A Drug to Drug Interaction Study of Sotagliflozin With Midazolam and Metoprolol
NCT02940379
Drug-drug Interaction Between Digoxin, Furosemide, Metformin, and Rosuvastatin
NCT02231931
Effect of Rosiglitazone on ADMA in Critical Illness
NCT00409097
Drug-drug Interaction Study Between UIC201603, and UIC201604
NCT06568133
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Demographic data (age, gender),clinical history data (main diagnosis, ICU stay in days, transfer from emergency room or other departments, on mechanical ventilation or not, state of consciousness
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Survey for drug drug interactions on medscape and lexicomp applications
Survey for drug drug interactions on Medscape and Lexicomp interaction checker applications
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zagazig University
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Liza Elsayed Ali soliman shallouf
Principle investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Liza Shallouf
Role: PRINCIPAL_INVESTIGATOR
Zagazig University
Heba Matar
Role: STUDY_DIRECTOR
Zagazig University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Liza Elsayed Ali
Zagazig, Sharquia, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4606/28-5-2018
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.